UpHealth(UPHL)
$0.010.00 (0.00%)
UPHL
UpHealth financials statements
$0.01
At close:0.00 (0.00%)
Want to see UPHL full AI Analyst Report?
UpHealth (UPHL) Ratios
330 Followers
UpHealth Ratios
UPHL's free cash flow for Q1 2024 was $-6.57M. For the 2024 fiscal year, UPHL's free cash flow was increased by $0.00 and operating cash flow was $-6.57M. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.75 | 0.63 | 1.10 | 0.36 | 5.12 |
| Quick Ratio | 0.75 | 0.63 | 1.07 | 0.36 | 5.12 |
| Cash Ratio | 0.09 | 0.23 | 0.79 | 0.07 | 4.64 |
| Solvency Ratio | -0.26 | -0.86 | -1.38 | -0.04 | 1.06 |
| Operating Cash Flow Ratio | -0.66 | -0.33 | -0.65 | -0.03 | -4.35 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -2.76 | -0.05 | 0.00 |
| Net Current Asset Value | $ -156.50M | $ -190.34M | $ -128.72M | $ -28.98M | $ 1.40M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.66 | 0.47 | 0.22 | 0.09 | 0.00 |
| Debt-to-Equity Ratio | 2.78 | 1.53 | 0.40 | 0.11 | 0.00 |
| Debt-to-Capital Ratio | 0.74 | 0.60 | 0.28 | 0.10 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.73 | 0.58 | 0.24 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.21 | 3.23 | 1.79 | 1.19 | 1.00 |
| Debt Service Coverage Ratio | -0.56 | -6.59 | -7.17 | -0.07 | 0.00 |
| Interest Coverage Ratio | -3.18 | -0.95 | -2.30 | -14.37 | 0.00 |
| Debt to Market Cap | 36.03 | 6.10 | 0.51 | 0.04 | 0.00 |
| Interest Debt Per Share | 10.24 | 12.72 | 13.65 | 4.48 | 0.00 |
| Net Debt to EBITDA | -8.92 | -0.79 | -0.16 | -13.05 | 1.65 |
| Profitability Margins | |||||
| Gross Profit Margin | 53.54% | 34.01% | 24.67% | 72.15% | 0.00% |
| EBIT Margin | -22.65% | -129.61% | -261.12% | -35.64% | 0.00% |
| EBITDA Margin | -13.00% | -115.86% | -246.86% | -29.71% | 0.00% |
| Operating Profit Margin | -68.90% | -15.77% | -36.23% | -35.69% | 0.00% |
| Pretax Profit Margin | -44.33% | -146.29% | -276.89% | -39.60% | 0.00% |
| Net Profit Margin | -44.49% | -140.43% | -275.47% | -40.53% | 0.00% |
| Continuous Operations Profit Margin | -43.40% | -140.38% | -274.92% | -40.53% | 0.00% |
| Net Income Per EBT | 100.36% | 95.99% | 99.49% | 102.34% | 39.21% |
| EBT Per EBIT | 64.34% | 927.68% | 764.35% | 110.96% | -96.42% |
| Return on Assets (ROA) | -24.95% | -65.63% | -59.90% | -0.83% | 0.21% |
| Return on Equity (ROE) | -104.96% | -212.08% | -107.08% | -0.99% | 0.21% |
| Return on Capital Employed (ROCE) | -43.70% | -9.25% | -9.49% | -0.85% | -0.54% |
| Return on Invested Capital (ROIC) | -42.05% | -8.70% | -8.95% | -0.77% | -0.21% |
| Return on Tangible Assets | -44.91% | -149.90% | -200.93% | -3.11% | 0.21% |
| Earnings Yield | -1422.23% | -930.74% | -142.25% | -0.38% | 0.16% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.86 | 7.26 | 5.43 | 0.81 | 0.00 |
| Payables Turnover | 5.15 | 5.83 | 6.85 | 0.56 | 0.00 |
| Inventory Turnover | 0.00 | 650.86 | 31.85 | 12.85 | 0.00 |
| Fixed Asset Turnover | 11.37 | 7.46 | 2.21 | 35.74 | 0.00 |
| Asset Turnover | 0.56 | 0.47 | 0.22 | 0.02 | 0.00 |
| Working Capital Turnover Ratio | -8.06 | -20.35 | -20.40 | -0.52 | 0.00 |
| Cash Conversion Cycle | -29.66 | -11.82 | 25.44 | -169.01 | 0.00 |
| Days of Sales Outstanding | 41.18 | 50.26 | 67.23 | 453.41 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.56 | 11.46 | 28.41 | 0.00 |
| Days of Payables Outstanding | 70.84 | 62.64 | 53.25 | 650.83 | 0.00 |
| Operating Cycle | 41.18 | 50.82 | 78.69 | 481.82 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.00 | -1.53 | -5.87 | -0.22 | -0.66 |
| Free Cash Flow Per Share | -1.22 | -1.99 | -6.22 | -0.22 | -0.66 |
| Dividend Paid and CapEx Coverage Ratio | -4.45 | -3.28 | -16.87 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -4.45 | -3.28 | -16.87 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.12 | -0.14 | -0.50 | -0.05 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.14 | -0.14 | -0.51 | -0.21 | 0.00 |
| Free Cash Flow Yield | -531.99% | -122.19% | -27.75% | -0.20% | -0.67% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.07 | -0.11 | -0.70 | -262.10 | 614.06 |
| Price-to-Sales (P/S) Ratio | 0.03 | 0.15 | 1.94 | 106.23 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.07 | 0.23 | 0.75 | 2.60 | 1.26 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.19 | -0.82 | -3.60 | -503.26 | -149.82 |
| Price-to-Operating Cash Flow Ratio | -0.23 | -1.07 | -3.82 | -503.26 | -149.82 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | -0.00 | 0.72 | 0.00 |
| Enterprise Value Multiple | -9.16 | -0.92 | -0.95 | -370.64 | -230.49 |
| Enterprise Value | 154.84M | 168.86M | 289.49M | 594.14M | 219.76M |
| EV to EBITDA | -9.16 | -0.92 | -0.95 | -370.64 | -230.49 |
| EV to Sales | 1.19 | 1.06 | 2.34 | 110.11 | 0.00 |
| EV to Free Cash Flow | -7.16 | -5.77 | -4.35 | -521.63 | -148.75 |
| EV to Operating Cash Flow | -8.76 | -7.52 | -4.61 | -521.63 | -148.75 |
| Tangible Book Value Per Share | -2.70 | -5.78 | -6.14 | 5.49 | 78.86 |
| Shareholders’ Equity Per Share | 3.11 | 7.15 | 29.76 | 42.16 | 78.86 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.04 | 0.01 | -0.02 | 0.61 |
| Revenue Per Share | 7.33 | 10.80 | 11.57 | 1.03 | 0.00 |
| Net Income Per Share | -3.26 | -15.17 | -31.86 | -0.42 | 0.16 |
| Tax Burden | 1.00 | 0.96 | 0.99 | 1.02 | 0.39 |
| Interest Burden | 1.96 | 1.13 | 1.06 | 1.11 | 1.00 |
| Research & Development to Revenue | 0.03 | 0.05 | 0.06 | 0.16 | 0.00 |
| SG&A to Revenue | 0.33 | 0.35 | 0.43 | 0.92 | 0.00 |
| Stock-Based Compensation to Revenue | 0.03 | 0.04 | 0.01 | 0.00 | 0.00 |
| Income Quality | 0.31 | 0.10 | 0.18 | 0.52 | -4.10 |
Currency in USD

